[68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.

DRUG3 trials

Sponsors

University of California, Davis

Conditions

Locally Advanced Pancreatic AdenocarcinomaMetastatic CancerMetastatic Nonsmall Cell Lung CancerMetastatic Pancreatic Cancer

Early Phase 1

First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer

Active, not recruitingNCT04665947

University of California, DavisLocally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer

Start: 2020-12-18End: 2027-12-31Target: 30Updated: 2026-09-11

Phase 1

Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

RecruitingNCT06228482

University of California, DavisMetastatic Nonsmall Cell Lung Cancer

Start: 2024-01-22End: 2027-01-01Target: 40Updated: 2026-02-27

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

RecruitingNCT06389123

University of California, DavisMetastatic Cancer

Start: 2024-04-01End: 2029-12-31Target: 40Updated: 2026-09-11